Back
Janux Therapeutics Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
JANX
Janux Therapeutics
Last Price:
$29.72
Seasonality Move:
3.51%
7 Day Trial
ALL ACCESS PASS
$
7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing slight selling pressure.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.59 | Sell |
20-day SMA: | 30.95 | Sell |
50-day SMA: | 36.52 | Sell |
200-day SMA: | 44.88 | Sell |
8-day EMA: | 30.54 | Sell |
20-day EMA: | 31.78 | Sell |
50-day EMA: | 36.57 | Sell |
200-day EMA: | 41.5 | Sell |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.89 | Sell |
Relative Strength Index (14 RSI): | 37.92 | Sell |
Chaikin Money Flow: | -93215 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.71 - 33.87) | Sell |
Bollinger Bands (100): | (34.97 - 56.03) | Sell |
Janux Therapeutics Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 29.78 while JANX 8-day simple moving average is 30.59, which is a Sell signal.
-
The stock price of JANX is 29.78 while Janux Therapeutics 20-day SMA is 30.95, which makes it a Sell.
-
Janux Therapeutics 50-day simple moving average is 36.52 while JANX share price is 29.78, making it a Sell technically.
-
JANX stock price is 29.78 and Janux Therapeutics 200-day simple moving average is 44.88, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
44
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a SellThe current Janux Therapeutics [JANX] share price is $29.78. The Score for JANX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
1.8B
Price in USD:
29.78
Share Volume:
865.6K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
28.92
Sell
44
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 29.78 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 29.78 while JANX 8-day exponential moving average is 30.54, which is a Sell signal.
-
The stock price of JANX is 29.78 while Janux Therapeutics 20-day EMA is 31.78, which makes it a Sell.
-
Janux Therapeutics 50-day exponential moving average is 36.57 while JANX share price is 29.78, making it a Sell technically.
-
JANX stock price is 29.78 and Janux Therapeutics 200-day simple moving average is 41.50, creating a Sell signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is -1.89, suggesting Janux Therapeutics is a Sell
-
Janux Therapeutics Relative Strength Index (RSI) is 37.92, which suggest Janux Therapeutics is oversold
-
The Bollinger Bands (25) for Janux Therapeutics is (29.71 - 33.87), which suggest Janux Therapeutics is a Sell
-
The Bollinger Bands (100) for Janux Therapeutics is (34.97 - 56.03), which suggest Janux Therapeutics is a Sell
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.